Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...

(Reuters) - Eli Lilly plans to launch its blockbuster ... Outside the U.S., the company has plants in Ireland, Italy and Spain. Lilly has forecast total sales to be between $58 billion and $ ...

Eli Lilly plans to launch its diabetes and weight-loss drug, Mounjaro, in emerging markets such as India, Brazil, and Mexico in 2025. The expansion leverages growing demand in populous countries ...

(Reuters) - Eli Lilly plans to launch its blockbuster diabetes and ... Outside the U.S., the company has plants in Ireland, Italy and Spain. Lilly has forecast total sales to be between $58 billion ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...

ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...

The pharmaceutical industry is not stopping there. There are already 100 new drug candidates in trials, all vying for a slice ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive ...